skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration
Executive Summary

According to the National Institutes of Health, 126.1 million adults in the U.S. (or 40.1% of the population) report experiencing some pain in the previous 3 months, with 25.3 million (or 8.1%) suffering from chronic pain and 23.4 million (or 7.4%) reporting high pain levels (Nahin, 2015). According to the American Pain Society, the direct and indirect costs of pain in the U.S. total between $560 billion and $635 billion, with direct healthcare costs accounting for 47% and indirect costs such as lost worker productivity accounting for the remaining 53%. Pain-related costs exceed those of heart disease ($309 billion), cancer ($243 billion), and diabetes ($188 billion) (Gaskin, 2012).

U.S. Markets Approaches to Pain Managment

Multidisciplinary pain management plans may involve the use of pharmacologic, device-based, or alternative therapies; a combination of these modalities often is required to achieve optimal pain relief, particularly for those suffering from chronic pain. A major trend driving the innovation and development of improved pain management treatments in the pain management industry is the demographics of the aging United States (U.S.) population.
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management Meddevicetracker.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: